Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Autobahn Therapeutics, Inc.

Autobahn Therapeutics, Inc.

Stage unknownSan Diego, CABiotechnology
Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1
Financing history
1 rounds
  1. Jun 20, 2024
    Form D equity offering · $101M (form d sold) · 22 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Autobahn Therapeutics, Inc. filed Form D: $100,825,289 sold of $120,000,000, Biotechnology”
Investors on record
1 edges
People
2 officers, 8 directors
Timeline
1
  1. Aug 1, 2024
    Autobahn Therapeutics, Inc. filed Form D: $100,825,289 sold of $120,000,000, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
16 observations
Every observation on this company